Endogenous Erythropoietin Protects Neuroretinal Function in Ischemic Retinopathy
Open Access
- 1 April 2012
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 180 (4) , 1726-1739
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (074617/Z/04/Z)
- Medical Research Council (G03000341)
- UCL Institute of Ophthalmology, University College London
- National Institute for Health Research
This publication has 75 references indexed in Scilit:
- Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of lifeJournal of Clinical Investigation, 2010
- Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic RetinopathyPLOS ONE, 2010
- HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal IschaemiaPLOS ONE, 2010
- Involvement of Erythropoietin in Retinal Ischemic PreconditioningAnesthesiology, 2009
- Suppression of Retinal Neovascularization by Erythropoietin siRNA in a Mouse Model of Proliferative RetinopathyInvestigative Ophthalmology & Visual Science, 2009
- Erythropoetin receptor expression in the human diabetic retinaBMC Research Notes, 2009
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLOS ONE, 2008
- Erythropoietin deficiency decreases vascular stability in miceJournal of Clinical Investigation, 2008
- Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment ModalitiesCurrent Eye Research, 2008
- The Oscillatory Potentials of the Dark-Adapted Electroretinogram in Retinopathy of PrematurityInvestigative Ophthalmology & Visual Science, 2007